Ho Jang

4PUBLICATIONS
10CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2025
Copy Number Alteration Profiling from Plasma cfDNA WES in Advanced NSCLC.

Ho Jang, Mi-Kyung Jeong

|Feb 22, 2025
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial.

Eunbyul Cho, Jin-Mu Yi, Jaemoo Chun

|Mar 11, 2023
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial.

Mi Mi Ko, Mi-Kyung Jeong, Chang Min Choi

|Nov 11, 2022
Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer.

Ho Jang, Chang-Min Choi, Seung-Hyeun Lee

Pageof 1

Frequent Collaborators

4 joint publications

Mi-Kyung Jeong

3 joint publications

Seung-Hyeun Lee

2 joint publications

Chang-Min Choi

2 joint publications

Jaemoo Chun